C5 and paroxysmal nocturnal hemoglobinuria: Indeed, the mean proportion of PNH RBCs that are positive for C3 fragment deposition (an indicator of EVH) is markedly increased in PNH patients on C5 inhibitor therapy compared to untreated PNH patients [17,18].